Jump to content
Frequently Asked Questions About Celiac Disease Read more... ×
  • Sign Up
Scott Adams

News: Celiac.com: ImmunogenX to Make Highlighted Presentations at DDW 2017

Rate this topic

Recommended Posts

The company is developing Latiglutenase (formerly ALV003) for celiac disease therapy. ImmunogenX is also developing a minimally-invasive ...

View the full article

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now